Morse; David L.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Morse; David L..The latest application filed is for "conjugates for detection of axillary lymph node metastases".
Company Profile
14.28.23
- Morse; David L. - Tampa FL
- Morse; David L - Tucson AZ
- Morse; David L. - Tucson AZ
- Morse; David L. - Corning NY
- Morse; David L. - West Lafayette IN
Patent Activity
| Patent | Date |
|---|---|
| Toll-like receptor 2 ligands and methods of making and using thereof Grant 11,414,455 - Morse , et al. August 16, 2 | 2022-08-16 |
| Melanocortin 1 receptor ligands and methods of use Grant 11,230,568 - Gillies , et al. January 25, 2 | 2022-01-25 |
| Conjugates For Detection Of Axillary Lymph Node Metastases App 20220001038 - Morse; David L. ; et al. | 2022-01-06 |
| Method and compositions for orally administered contrast agents for MR imaging Grant 11,207,429 - Mash , et al. December 28, 2 | 2021-12-28 |
| Molecular imaging of cancer cells in vivo Grant 11,077,212 - Morse , et al. August 3, 2 | 2021-08-03 |
| Toll-like Receptor 2 Ligands And Methods Of Making And Using Thereof App 20210230219 - Morse; David L. ; et al. | 2021-07-29 |
| Toll-like receptor 2 ligands and methods of making and using thereof Grant 10,793,595 - Morse , et al. October 6, 2 | 2020-10-06 |
| Delta-opioid Receptor Targeted Agent For Molecular Imaging And Immunotherapy Of Cancer App 20200197530 - McLaughlin; Mark L. ; et al. | 2020-06-25 |
| Conjugates For Immunotherapy App 20200188472 - MCLAUGHLIN; Mark ; et al. | 2020-06-18 |
| Molecular Imaging of Cancer Cells In Vivo App 20200164093 - Morse; David L. ; et al. | 2020-05-28 |
| Melanocortin 1 Receptor Ligands And Methods Of Use App 20200002376 - GILLIES; ROBERT J. ; et al. | 2020-01-02 |
| Conjugates for immunotherapy Grant 10,449,227 - McLaughlin , et al. Oc | 2019-10-22 |
| Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer Grant 10,426,843 - McLaughlin , et al. October 1, 2 | 2019-10-01 |
| Molecular imaging of cancer cells in vivo Grant 10,406,248 - Morse , et al. Sept | 2019-09-10 |
| Toll-like Receptor 2 Ligands And Methods Of Making And Using Thereof App 20190263857 - Morse; David L. ; et al. | 2019-08-29 |
| A Delta-opioid Receptor Targeted Agent For Molecular Imaging And Immunotherapy Of Cancer App 20190192685 - McLaughlin; Mark L. ; et al. | 2019-06-27 |
| Melanocortin 1 receptor ligands and methods of use Grant 10,329,326 - Gillies , et al. | 2019-06-25 |
| Method of increasing intratumoral pHe and reducing acid-mediated invasion Grant 10,258,607 - Gillies , et al. | 2019-04-16 |
| Toll-like receptor 2 ligands and methods of making and using thereof Grant 10,118,942 - Morse , et al. November 6, 2 | 2018-11-06 |
| Toll-like Receptor 2 Ligands And Methods Of Making And Using Thereof App 20180051055 - Morse; David L. ; et al. | 2018-02-22 |
| Melanocortin 1 Receptor Ligands And Methods Of Use App 20170218017 - GILLIES; ROBERT J. ; et al. | 2017-08-03 |
| Method And Compositions For Orally Administered Contrast Agents For Mr Imaging App 20170209602 - Mash; Eugene A. ; et al. | 2017-07-27 |
| Conjugates For Immunotherapy App 20170202902 - MCLAUGHLIN; Mark ; et al. | 2017-07-20 |
| Melanocortin 1 receptor ligands and methods of use Grant 9,441,013 - Gillies , et al. September 13, 2 | 2016-09-13 |
| Molecular Imaging Probes For Lung Cancer Intraoperative Guidance App 20160051704 - Morse; David L. ; et al. | 2016-02-25 |
| Molecular Imaging of Cancer Cells In Vivo App 20140161725 - Morse; David L. ; et al. | 2014-06-12 |
| Melanocortin 1 Receptor Ligands And Methods Of Use App 20140112873 - Gillies; Robert J. ; et al. | 2014-04-24 |
| Method Of Screening For Colon Cancer Using Biomarkers App 20140105827 - Morse; David L. ; et al. | 2014-04-17 |
| Molecular Imaging of Cancer Cells In Vivo App 20130129619 - Morse; David L. ; et al. | 2013-05-23 |
| Method of Increasing Intratumoral pHe and Reducing Acid-Mediated Invasion App 20120277245 - Gillies; Robert J. ; et al. | 2012-11-01 |
| Methods of identifying pancreatic cancer cells Grant 7,816,082 - Han , et al. October 19, 2 | 2010-10-19 |
| Methods of Identifying Pancreatic Cancer Cells App 20080261818 - Han; Haiyong ; et al. | 2008-10-23 |
| Stretched glass with high birefringence App 20060122050 - Borrelli; Nicholas F. ; et al. | 2006-06-08 |
| Detachable fiber optic connector with improved optical sub-assembly and nose block Grant 5,937,125 - Creswick , et al. August 10, 1 | 1999-08-10 |
| Small anamorphic lenses and method Grant 4,684,222 - Borrelli , et al. August 4, 1 | 1987-08-04 |
| Photochromic glass compositions for lightweight lenses Grant 4,608,349 - Kerko , et al. August 26, 1 | 1986-08-26 |
| Apparatus including an integral optical device Grant 4,572,611 - Bellman , et al. February 25, 1 | 1986-02-25 |
| Ultraviolet absorbing photochromic glass of low silver content Grant 4,549,894 - Araujo , et al. October 29, 1 | 1985-10-29 |
| Integral optical device and method of making it Grant 4,488,864 - Borrelli , et al. December 18, 1 | 1984-12-18 |
| Very fast fading photochromic glass Grant 4,407,966 - Kerko , et al. October 4, 1 | 1983-10-04 |
| Method for providing optical patterns in glass Grant 4,403,031 - Borrelli , et al. September 6, 1 | 1983-09-06 |
| Glass-encapsulated magnetic materials and methods for making them Grant 4,360,441 - Borrelli , et al. November 23, 1 | 1982-11-23 |
| Photochromic glass suitable for microsheet and simultaneous heat treatment and shaping Grant 4,358,542 - Hares , et al. November 9, 1 | 1982-11-09 |
| Photochromic glass Grant 4,190,451 - Hares , et al. February 26, 1 | 1980-02-26 |
Company Registrations
| SEC | 0001547488 | Morse David L |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 